OTCMKTS:EKTAY

Elekta Q4 2024 Earnings Results & Report

Elekta logo
$6.21 0.00 (0.00%)
As of 11/16/2026

Elekta reported Q4 2024 earnings on June 5, 2024. The company reported EPS of $0.11, while revenue was $475.78 million.

Earnings Announcement Details

Quarter
Q4 2024
Report Date

Elekta EPS Results

Actual EPS
$0.11
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$475.78 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Q4 2024 Earnings FAQ

Elekta (OTCMKTS:EKTAY) reported earnings of $0.11 per share for Q4 2024. The report was announced on Wednesday, June 5, 2024.

Elekta reported revenue of $475.78 million for Q4 2024.

Elekta's next earnings date is estimated for Wednesday, November 25, 2026. MarketBeat tracks confirmed and estimated earnings dates for Elekta on the company's earnings history page.

Elekta Earnings Headlines

Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Swedish medical technology company that develops equipment and software for radiation therapy and other treatments used in cancer care and neurosurgery. Founded in 1972 by neurosurgeon Lars Leksell, the company builds on his work in stereotactic radiosurgery.

Its offerings include linear accelerators for external-beam radiation therapy, systems for stereotactic radiosurgery and brachytherapy, and software that helps healthcare providers plan and manage treatment. Elekta’s technologies are used by hospitals and clinics to deliver care for cancer and certain neurological conditions.

The company serves healthcare providers in markets around the world. Its work spans equipment, treatment-planning tools, and clinical information systems designed to support radiation oncology services.

View Elekta Profile